Developing a supportive and palliative care intervention for patients with allogeneic stem cell transplantation: protocol of a multicentre mixed-methods study (allo-PaS)Anne Pralong, Marco Herling, Udo Holtick, Christoph Scheid, Martin Hellmich, Michael Hallek, Berenike Pauli, Alinda Reimer, Carolin Schepers, Steffen T Simon
31 August 2023
Experiences and preferences for psychosocial support: a qualitative study exploring the views of patients with chronic haematological cancersRebecca Sheridan, Dorothy McCaughan, Ann Hewison, Eve Roman, Alexandra Smith, Russell Patmore, Debra Howell
18 August 2023
Construction and validation of a risk prediction model for perianal infection in patients with haematological malignancies during chemotherapy: a prospective study in a tertiary hospital in ChinaYingli Wang, Yuqin Luo, Yamei Leng, Mei Yang, Taoyun Liang, Ting Niu
18 August 2023
Development of prospective hospital-based venous thromboembolism registry across India: a study protocolHeena Tabassum, Sumit Aggarwal, Geetha R Menon, Narendra Arora, Sagnik Chakraborty, M V Rao, Balram Bhargava, Nabendu S Chatterjee
9 August 2023
Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trialMasahiro Takeyama, Naoki Ozu, Shu Kasama, Masato Kasahara, Masanori Matsumoto, Midori Shima, Keiji Nogami
10 July 2023
Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysisXiangge Ren, Miaomiao Zhang, Xiaohan Zhang, Peidong Zhao, Wensheng Zhai
29 June 2023
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia AAnouk Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
26 June 2023
ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remissionDavid I Marks, Anna Castleton, Eduardo Olavarria, Maria Gilleece, Adele Fielding, George Mikhaeel, Matthew Beasley, Patricia Diez, Aimee Jackson, Andrea Hodgkinson, Mohamed Elhanied, Ronjon Chakraverty
1 June 2023
Effect of cognitive–behavioural therapy on resilience and relapse in adult patients with substance use disorder: a systematic review protocolIbraheem Mhaidat, Mohammad Reza Taherian, Seyed Saeed Hashemi Nazari, Alireza Mosavi-Jarrahi, Haniye Yeganeh, Nabeel Al-Yateem, Amina M Al Marzouqi, Syed Azizur Rahman
12 May 2023
Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study)Aurore Dougé, Aurélie Ravinet, Alexandrine Corriger, Aurélie Cabrespine, Mathieu Wasiak, Bruno Pereira, Harry Sokol, Stéphanie Nguyen, Jacques-Olivier Bay
2 May 2023
